- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 03.12.25 | Workplaces labor to keep staff as fertility support falls short, Ferring survey finds | ||
| 02.12.25 | CDER head Richard Pazdur set to retire shortly after appointment | ||
| 02.12.25 | Incyte taps Winnie Harlow to model vitiligo awareness, empowerment in new campaign | ||
| 02.12.25 | Lawmakers dig in on biopharma manufacturing with bill proposing US center of excellence | ||
| 02.12.25 | House endorses bill that would revive FDA's rare pediatric review voucher program | ||
| 02.12.25 | Pharmas have promised $370B in US investments amid 2025's onshoring boom: DPR | ||
| 02.12.25 | Regulatory tracker: Eisai finalizes FDA filing for subcutaneous Leqembi starter dose | ||
| 01.12.25 | FDA's Prasad tells staffers agency plans to get tougher on vaccine regulation, blames child deaths on COVID shots | ||
| 01.12.25 | Tanabe Pharma shifts gears for Bain-backed future, dropping Mitsubishi moniker after $3.3B deal | ||
| 01.12.25 | Microsize, Schedio link to buy Lonza's Swiss micronization plant | ||
| 01.12.25 | Close of Omnicom-Interpublic megamerger brings new health CEO, 4K layoffs | ||
| 01.12.25 | In UK trade deal, Trump administration excludes drugs from tariffs and secures promise of more pharma investment | ||
| 01.12.25 | Lilly lowers self-pay prices of single-dose Zepbound vials | ||
| 26.11.25 | Medicare unveils price reductions for 15 drugs, including Novo's semaglutide | ||
| 26.11.25 | Novo cashes in FDA national priority voucher for extra-speedy review of high-dose Wegovy | ||
| 26.11.25 | In crowded kidney disease space, Otsuka receives FDA approval for first-in-class Voyxact | ||
| 26.11.25 | French authorities raid Sanofi headquarters in tax fraud probe | ||
| 25.11.25 | Calling all rising stars in pharma marketing: Nominations open for Fierce feature series | ||
| 25.11.25 | Sarepta gets FDA's go-ahead to study immunosuppressive Elevidys regimen in bid to reverse label restriction | ||
| 25.11.25 | AbbVie short film showcases 'Second Winds' of life after CLL diagnosis | ||
| 25.11.25 | Pharma pros skeptical of letting AI loose on regulatory compliance submissions: survey | ||
| 25.11.25 | Lawmakers probe FDA's new priority voucher program, cite corruption and rushed review concerns | ||
| 25.11.25 | Novartis to cut 550 jobs at plant in Switzerland by end of 2027 | ||
| 25.11.25 | Novartis scores FDA approval for new version of SMA gene therapy, prices at $2.59M | ||
| 25.11.25 | Angelini faces UK marketing watchdog's wrath after speaker blasts 'stupid' EMA |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .